SAMANTHA PERSON-ALDRIDGE: Open Payments
NPI 1003331208 · BARTLETT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 47 payments from 12 companies in 2025. Trend: 2023 $1,846 · 2024 $1,225 · 2025 $1,396
Food & beverage: $1,396
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $254 |
| Alkermes, Inc. | 8 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $187 |
| ABBVIE INC. | 7 | $170 |
| Supernus Pharmaceuticals, Inc. | 2 | $139 |
| Vanda Pharmaceuticals Inc. | 2 | $136 |
| Axsome Therapeutics, Inc. | 5 | $104 |
| Janssen Pharmaceuticals, Inc | 3 | $65 |
| Lundbeck LLC | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
Products named: REXULTI, CAPLYTA, ARISTADA, VRAYLAR, Qelbree, FANAPT, Auvelity, SPRAVATO.
Industry payments across TN — which companies pay providers there.
